[go: up one dir, main page]

AU2001268973A1 - Method for using transfectable constructions from luciferase and from the promotor of the human period 1 gene for identifying novel active substances that influence the day/night rhythm and sleep - Google Patents

Method for using transfectable constructions from luciferase and from the promotor of the human period 1 gene for identifying novel active substances that influence the day/night rhythm and sleep

Info

Publication number
AU2001268973A1
AU2001268973A1 AU2001268973A AU6897301A AU2001268973A1 AU 2001268973 A1 AU2001268973 A1 AU 2001268973A1 AU 2001268973 A AU2001268973 A AU 2001268973A AU 6897301 A AU6897301 A AU 6897301A AU 2001268973 A1 AU2001268973 A1 AU 2001268973A1
Authority
AU
Australia
Prior art keywords
transfectable
promotor
luciferase
sleep
constructions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001268973A
Inventor
Urs. Albrecht
Sabine Loumi
Erik Maronde
Dirk Motzkus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IPF Pharmaceuticals GmbH
Original Assignee
IPF Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IPF Pharmaceuticals GmbH filed Critical IPF Pharmaceuticals GmbH
Publication of AU2001268973A1 publication Critical patent/AU2001268973A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/204IL-6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2278Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2864Sleep disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU2001268973A 2000-04-18 2001-04-18 Method for using transfectable constructions from luciferase and from the promotor of the human period 1 gene for identifying novel active substances that influence the day/night rhythm and sleep Abandoned AU2001268973A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10019360.9 2000-04-18
DE10019360 2000-04-18
PCT/EP2001/004383 WO2001079539A2 (en) 2000-04-18 2001-04-18 Method for using transfectable constructions from luciferase and from the promotor of the human period 1 gene for identifying novel active substances that influence the day/night rhythm and sleep

Publications (1)

Publication Number Publication Date
AU2001268973A1 true AU2001268973A1 (en) 2001-10-30

Family

ID=7639288

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001268973A Abandoned AU2001268973A1 (en) 2000-04-18 2001-04-18 Method for using transfectable constructions from luciferase and from the promotor of the human period 1 gene for identifying novel active substances that influence the day/night rhythm and sleep

Country Status (2)

Country Link
AU (1) AU2001268973A1 (en)
WO (1) WO2001079539A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1248107A3 (en) * 2001-03-22 2002-10-16 IPF Pharmaceuticals GmbH Method and device for time-resolved screening
CN114306607A (en) * 2021-12-31 2022-04-12 中国人民解放军军事科学院军事医学研究院 Primary cilia regulate biological rhythms and their related applications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2260763A1 (en) * 1996-07-18 1998-01-29 The General Hospital Corporation Melatonin 1a receptor gene regulatory regions and uses thereof
WO1999012952A1 (en) * 1997-09-09 1999-03-18 Research Development Foundation Mammalian circadian rhythm-like gene

Also Published As

Publication number Publication date
WO2001079539A2 (en) 2001-10-25
WO2001079539A9 (en) 2003-05-22
WO2001079539A3 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
HUP0202705A3 (en) Methods and microorganisms or production of panto-compounds
AU3549697A (en) Extracting particles produced by the treating of human or animal nails
DE69812784D1 (en) Composition for the prevention and elimination of plant diseases
AU3622600A (en) Metalloproteinases and methods of use therefor
AU2058697A (en) Treatment of sleep disorders
PL313858A1 (en) Method of making inactive or killing microorganisms
AU7958100A (en) Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
AU7222598A (en) Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants
DE69420229D1 (en) Pharmaceutical composition for the treatment of AIDS
EP0922387A4 (en) Method of screening elicitor inducing the production of phytoalexin in rice and rice disease controlling agent containing elicitor as the active ingredient
AU2335597A (en) Antibacterially active marine algae extracts from the class diatomatae and methods of use
GB9929497D0 (en) Improved amino acid mixtures for the treatment and/or management of certain diseases
AU2001268973A1 (en) Method for using transfectable constructions from luciferase and from the promotor of the human period 1 gene for identifying novel active substances that influence the day/night rhythm and sleep
DE69724613D1 (en) Antimicrobial agents against eukaryotic microorganisms and methods for suppressing the growth of eukaryotic microorganisms using such agents
AU2139097A (en) Methods of treating or preventing sleep apnea
AU764930C (en) Plant photoperiod sensitivity gene and use of the same
DE59914312D1 (en) USE OF HYDROXYPYRIDONE-CONTAINING POWDER PREPARATIONS FOR THE TREATMENT OF SUB-PRESSURE AND PRESSURE DISORDERS
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
AU5779798A (en) Culture unit and method of manufacturing the same
AU6548396A (en) Methods for selectively killing or inhibiting the growth of cells expressing the waf1 gene
AU1103701A (en) Glutamate transporter associated proteins and methods of use thereof
AU5419400A (en) Thienyl-pyrazoles and their use for controlling pests
AU2002343013A1 (en) Sequence variants of the human growth hormone gene and methods for detection
AU2002366072A1 (en) Systems and methods relating to determining the desirability of and recording programming events
AU4176200A (en) Novel genetic suppressor elements and methods of making the same